Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Circulating levels of CA 125, the HMFG2 antigen and placental alkaline phosphatase were measured in patients with epithelial ovarian cancer. In 37 patients the antigens were assayed before operation and 161 follow-up samples from 41 patients were assayed at different times during treatment. These three human tumour-associated antigens were expressed independently of each other. Measurement of all three antigens, compared with measurement of CA 125 alone, resulted in a statistically significant improvement in the detection rate of patients with localized disease from 18% to 69%.


Journal article


British journal of obstetrics and gynaecology

Publication Date





696 - 698


Placenta, Humans, Ovarian Neoplasms, Alkaline Phosphatase, Isoenzymes, Antigens, Tumor-Associated, Carbohydrate, Antibodies, Monoclonal, Antigens, Neoplasm, Antigens, Surface, Epitopes, Prospective Studies, Female, GPI-Linked Proteins